EXUDATIVE RETINOPATHY

This adverse event was reported 57 times

These drugs are most commonly taken by patients reporting EXUDATIVE RETINOPATHY:

# Drug Count
0 RANIBIZUMAB 14
1 BEVACIZUMAB 13
2 VERTEPORFIN FOR INJECTION 6
3 AFLIBERCEPT 4
4 SOMATROPIN 4
5 FINGOLIMOD HCL 3
6 CARBOPLATIN 2
7 DOXYCYCLINE 2
8 DOXYCYCLINE HYCLATE 2
9 FLUTICASONE PROPIONATE 2
See all common drugs associated with EXUDATIVE RETINOPATHY

EXUDATIVE RETINOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VERTEPORFIN FOR INJECTION 6 0.0041
1 RANIBIZUMAB 14 0.0005
2 PEGCETACOPLAN 1 0.0005
3 PENTOSAN POLYSULFATE SODIUM 1 0.0001
4 AFLIBERCEPT 4 0.0001
5 BEVACIZUMAB 13 0.0001
6 PRIMIDONE 1 0.0001
7 DOXEPIN HYDROCHLORIDE 1 0.0001
8 SOMATROPIN 4 0.0001
9 CEPHALEXIN 1 0.0000
See all drugs enriched for association with EXUDATIVE RETINOPATHY

EXUDATIVE RETINOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Photoenhancer [EPC] 6 0.0015
1 Vascular Endothelial Growth Factor Inhibitor [EPC] 28 0.0002
2 Recombinant Human Growth Hormone [EPC] 3 0.0001
3 Tetracycline-class Drug [EPC] 2 0.0000
4 Folate Analog [EPC] 1 0.0000
5 Vitamin A [EPC] 1 0.0000
6 Complement Inhibitor [EPC] 1 0.0000
7 Nicotinic Acid [EPC] 1 0.0000
8 BCL-2 Inhibitor [EPC] 1 0.0000
9 Antidote [EPC] 1 0.0000
See all drug classes enriched for association with EXUDATIVE RETINOPATHY